Rouce et al. observed that the dysfunction of NK cells from ALL patients results from the release of TGFβ1 by BCP-ALL cells, which leads to the activation of the TGFβ/SMAD pathway and in consequence to NK cell dysfunction [118]. This evidence concerns the gene OPN1SW and acute lymphoblastic leukemia.